サマリー

生物製剤の開発・製造受託機関（CDMO）の世界市場 2024-2028
生物製剤の開発・製造受託機関（CDMO）市場は、2023〜2028年に106億3000万米ドルの成長が予測され、予測期間中のCAGRは10.46%で加速すると予測されます。当レポートでは、生物製剤の開発・製造受託機関（CDMO）市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、新興市場におけるコスト効率の高いリソースの利用可能性、生物製剤治療薬の強力な研究開発パイプライン、コアコンピタンスに集中する必要性の高まりによって牽引されています。
Technavioの生物製剤開発製造受託機関（CDMO）市場は以下のように区分される：
タイプ別
- 哺乳類
- 微生物
製品タイプ別
- 生物製剤
- バイオシミラー
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間の生物製剤開発製造受託機関（CDMO）市場の成長を促進する主な理由の1つとして、ビッグデータの出現を挙げている。また、CDMOベンダーの製薬会社との戦略的提携やパートナーシップ、新規分子やバイオシミラーの承認の増加は、市場の大きな需要につながる。
本レポートでは、生物製剤の開発・製造受託機関（CDMO）市場について、以下の分野をカバーしている：
- 生物製剤開発製造受託機関（CDMO）市場のサイジング
- 生物製剤開発製造受託機関（CDMO）市場予測
- 生物製剤開発製造受託機関（CDMO）市場産業分析
本レポートでは、3P BIOPHARMACEUTICALS S.L.U.、AbbVie Inc.、AGC Biologics、Binex Co.Ltd.、Boehringer Ingelheim International GmbH、Bora Pharmaceuticals Co.Ltd.、Catalent Inc.、Evonik Industries AG、FUJIFILM Corp.、Grifols SA、J RETTENMAIER and SOHNE GmbH and Co KG、JSR Corp.、Kemwell Biopharma Pvt. Ltd.、Lonza Group Ltd.、Novartis AG、Rentschler Biopharma SE、Samsung Electronics Co.Ltd.、Shenzhen Hepalink Pharmaceutical Co.Ltd.、Novartis AG、Rentschler Biopharma SE、Samsung Electronics Co.Ltd.、WuXi Biologics Cayman Inc.などである。また、生物製剤開発製造受託機関（CDMO）市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、以下をご覧ください - [https://www.technavio.com/report/biologics-CDMO-market-industry-analysis](https://www.technavio.com/report/biologics-cdmo-market-industry-analysis)
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global biologics contract development and manufacturing organization (CDMO) market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global biologics contract development and manufacturing organization (cdmo) market 2018 - 2022 ($ billion)
o 4.2 Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
o 4.3 Product Type Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Product Type Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Mammalian - Market size and forecast 2023-2028
o Exhibit 34: Chart on Mammalian - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Mammalian - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Mammalian - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Mammalian - Year-over-year growth 2023-2028 (%)
o 6.4 Microbial - Market size and forecast 2023-2028
o Exhibit 38: Chart on Microbial - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Microbial - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Microbial - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Microbial - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ billion)
o Exhibit 43: Data Table on Market opportunity by Type ($ billion)
• 7 Market Segmentation by Product Type
o 7.1 Market segments
o Exhibit 44: Chart on Product Type - Market share 2023-2028 (%)
o Exhibit 45: Data Table on Product Type - Market share 2023-2028 (%)
o 7.2 Comparison by Product Type
o Exhibit 46: Chart on Comparison by Product Type
o Exhibit 47: Data Table on Comparison by Product Type
o 7.3 Biologics - Market size and forecast 2023-2028
o Exhibit 48: Chart on Biologics - Market size and forecast 2023-2028 ($ billion)
o Exhibit 49: Data Table on Biologics - Market size and forecast 2023-2028 ($ billion)
o Exhibit 50: Chart on Biologics - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
o 7.4 Biosimilars - Market size and forecast 2023-2028
o Exhibit 52: Chart on Biosimilars - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Biosimilars - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Biosimilars - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Biosimilars - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Product Type
o Exhibit 56: Market opportunity by Product Type ($ billion)
o Exhibit 57: Data Table on Market opportunity by Product Type ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 France - Market size and forecast 2023-2028
o Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 107: AbbVie Inc. - Overview
o Exhibit 108: AbbVie Inc. - Product / Service
o Exhibit 109: AbbVie Inc. - Key news
o Exhibit 110: AbbVie Inc. - Key offerings
o 12.4 Binex Co. Ltd.
o Exhibit 111: Binex Co. Ltd. - Overview
o Exhibit 112: Binex Co. Ltd. - Product / Service
o Exhibit 113: Binex Co. Ltd. - Key offerings
o 12.5 Boehringer Ingelheim International GmbH
o Exhibit 114: Boehringer Ingelheim International GmbH - Overview
o Exhibit 115: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 116: Boehringer Ingelheim International GmbH - Key news
o Exhibit 117: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 118: Boehringer Ingelheim International GmbH - Segment focus
o 12.6 Bora Pharmaceuticals Co. Ltd
o Exhibit 119: Bora Pharmaceuticals Co. Ltd - Overview
o Exhibit 120: Bora Pharmaceuticals Co. Ltd - Product / Service
o Exhibit 121: Bora Pharmaceuticals Co. Ltd - Key offerings
o 12.7 Catalent Inc.
o Exhibit 122: Catalent Inc. - Overview
o Exhibit 123: Catalent Inc. - Business segments
o Exhibit 124: Catalent Inc. - Key news
o Exhibit 125: Catalent Inc. - Key offerings
o Exhibit 126: Catalent Inc. - Segment focus
o 12.8 Evonik Industries AG
o Exhibit 127: Evonik Industries AG - Overview
o Exhibit 128: Evonik Industries AG - Business segments
o Exhibit 129: Evonik Industries AG - Key news
o Exhibit 130: Evonik Industries AG - Key offerings
o Exhibit 131: Evonik Industries AG - Segment focus
o 12.9 FUJIFILM Corp.
o Exhibit 132: FUJIFILM Corp. - Overview
o Exhibit 133: FUJIFILM Corp. - Business segments
o Exhibit 134: FUJIFILM Corp. - Key offerings
o Exhibit 135: FUJIFILM Corp. - Segment focus
o 12.10 Grifols SA
o Exhibit 136: Grifols SA - Overview
o Exhibit 137: Grifols SA - Business segments
o Exhibit 138: Grifols SA - Key offerings
o Exhibit 139: Grifols SA - Segment focus
o 12.11 J RETTENMAIER and SOHNE GmbH and Co KG
o Exhibit 140: J RETTENMAIER and SOHNE GmbH and Co KG - Overview
o Exhibit 141: J RETTENMAIER and SOHNE GmbH and Co KG - Product / Service
o Exhibit 142: J RETTENMAIER and SOHNE GmbH and Co KG - Key offerings
o 12.12 Lonza Group Ltd.
o Exhibit 143: Lonza Group Ltd. - Overview
o Exhibit 144: Lonza Group Ltd. - Business segments
o Exhibit 145: Lonza Group Ltd. - Key news
o Exhibit 146: Lonza Group Ltd. - Key offerings
o Exhibit 147: Lonza Group Ltd. - Segment focus
o 12.13 Novartis AG
o Exhibit 148: Novartis AG - Overview
o Exhibit 149: Novartis AG - Business segments
o Exhibit 150: Novartis AG - Key offerings
o Exhibit 151: Novartis AG - Segment focus
o 12.14 Rentschler Biopharma SE
o Exhibit 152: Rentschler Biopharma SE - Overview
o Exhibit 153: Rentschler Biopharma SE - Product / Service
o Exhibit 154: Rentschler Biopharma SE - Key offerings
o 12.15 Samsung Electronics Co. Ltd.
o Exhibit 155: Samsung Electronics Co. Ltd. - Overview
o Exhibit 156: Samsung Electronics Co. Ltd. - Business segments
o Exhibit 157: Samsung Electronics Co. Ltd. - Key news
o Exhibit 158: Samsung Electronics Co. Ltd. - Key offerings
o Exhibit 159: Samsung Electronics Co. Ltd. - Segment focus
o 12.16 Toyobo Co. Ltd.
o Exhibit 160: Toyobo Co. Ltd. - Overview
o Exhibit 161: Toyobo Co. Ltd. - Business segments
o Exhibit 162: Toyobo Co. Ltd. - Key offerings
o Exhibit 163: Toyobo Co. Ltd. - Segment focus
o 12.17 WuXi Biologics Cayman Inc.
o Exhibit 164: WuXi Biologics Cayman Inc. - Overview
o Exhibit 165: WuXi Biologics Cayman Inc. - Product / Service
o Exhibit 166: WuXi Biologics Cayman Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 167: Inclusions checklist
o Exhibit 168: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 169: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 170: Research methodology
o Exhibit 171: Validation techniques employed for market sizing
o Exhibit 172: Information sources
o 13.5 List of abbreviations
o Exhibit 173: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Product Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global biologics contract development and manufacturing organization (cdmo) market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Product Type Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Mammalian - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Mammalian - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Mammalian - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Mammalian - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Microbial - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Microbial - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Microbial - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Microbial - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ billion)
Exhibits43: Data Table on Market opportunity by Type ($ billion)
Exhibits44: Chart on Product Type - Market share 2023-2028 (%)
Exhibits45: Data Table on Product Type - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Product Type
Exhibits47: Data Table on Comparison by Product Type
Exhibits48: Chart on Biologics - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Biologics - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Biosimilars - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Biosimilars - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Biosimilars - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Biosimilars - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Product Type ($ billion)
Exhibits57: Data Table on Market opportunity by Product Type ($ billion)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ billion)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: AbbVie Inc. - Overview
Exhibits108: AbbVie Inc. - Product / Service
Exhibits109: AbbVie Inc. - Key news
Exhibits110: AbbVie Inc. - Key offerings
Exhibits111: Binex Co. Ltd. - Overview
Exhibits112: Binex Co. Ltd. - Product / Service
Exhibits113: Binex Co. Ltd. - Key offerings
Exhibits114: Boehringer Ingelheim International GmbH - Overview
Exhibits115: Boehringer Ingelheim International GmbH - Business segments
Exhibits116: Boehringer Ingelheim International GmbH - Key news
Exhibits117: Boehringer Ingelheim International GmbH - Key offerings
Exhibits118: Boehringer Ingelheim International GmbH - Segment focus
Exhibits119: Bora Pharmaceuticals Co. Ltd - Overview
Exhibits120: Bora Pharmaceuticals Co. Ltd - Product / Service
Exhibits121: Bora Pharmaceuticals Co. Ltd - Key offerings
Exhibits122: Catalent Inc. - Overview
Exhibits123: Catalent Inc. - Business segments
Exhibits124: Catalent Inc. - Key news
Exhibits125: Catalent Inc. - Key offerings
Exhibits126: Catalent Inc. - Segment focus
Exhibits127: Evonik Industries AG - Overview
Exhibits128: Evonik Industries AG - Business segments
Exhibits129: Evonik Industries AG - Key news
Exhibits130: Evonik Industries AG - Key offerings
Exhibits131: Evonik Industries AG - Segment focus
Exhibits132: FUJIFILM Corp. - Overview
Exhibits133: FUJIFILM Corp. - Business segments
Exhibits134: FUJIFILM Corp. - Key offerings
Exhibits135: FUJIFILM Corp. - Segment focus
Exhibits136: Grifols SA - Overview
Exhibits137: Grifols SA - Business segments
Exhibits138: Grifols SA - Key offerings
Exhibits139: Grifols SA - Segment focus
Exhibits140: J RETTENMAIER and SOHNE GmbH and Co KG - Overview
Exhibits141: J RETTENMAIER and SOHNE GmbH and Co KG - Product / Service
Exhibits142: J RETTENMAIER and SOHNE GmbH and Co KG - Key offerings
Exhibits143: Lonza Group Ltd. - Overview
Exhibits144: Lonza Group Ltd. - Business segments
Exhibits145: Lonza Group Ltd. - Key news
Exhibits146: Lonza Group Ltd. - Key offerings
Exhibits147: Lonza Group Ltd. - Segment focus
Exhibits148: Novartis AG - Overview
Exhibits149: Novartis AG - Business segments
Exhibits150: Novartis AG - Key offerings
Exhibits151: Novartis AG - Segment focus
Exhibits152: Rentschler Biopharma SE - Overview
Exhibits153: Rentschler Biopharma SE - Product / Service
Exhibits154: Rentschler Biopharma SE - Key offerings
Exhibits155: Samsung Electronics Co. Ltd. - Overview
Exhibits156: Samsung Electronics Co. Ltd. - Business segments
Exhibits157: Samsung Electronics Co. Ltd. - Key news
Exhibits158: Samsung Electronics Co. Ltd. - Key offerings
Exhibits159: Samsung Electronics Co. Ltd. - Segment focus
Exhibits160: Toyobo Co. Ltd. - Overview
Exhibits161: Toyobo Co. Ltd. - Business segments
Exhibits162: Toyobo Co. Ltd. - Key offerings
Exhibits163: Toyobo Co. Ltd. - Segment focus
Exhibits164: WuXi Biologics Cayman Inc. - Overview
Exhibits165: WuXi Biologics Cayman Inc. - Product / Service
Exhibits166: WuXi Biologics Cayman Inc. - Key offerings
Exhibits167: Inclusions checklist
Exhibits168: Exclusions checklist
Exhibits169: Currency conversion rates for US$
Exhibits170: Research methodology
Exhibits171: Validation techniques employed for market sizing
Exhibits172: Information sources
Exhibits173: List of abbreviations